FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Tipranavir Oral Solution
Status: Discontinuation
»Therapeutic Categories: Antiviral

Boehringer Ingelheim Pharmaceuticals, Inc. (New 06/29/2021)

Company Contact Information:
800-542-6257

Presentation Posting Date Related Information
100mg/mL (NDC 0597-0002-01) 06/29/2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English